See more : Hydrogen-Refueling-Solutions SA (ALHRS.PA) Income Statement Analysis – Financial Results
Complete financial analysis of Horizon Technology Finance Corporation (HRZN) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Horizon Technology Finance Corporation, a leading company in the Asset Management industry within the Financial Services sector.
- Telenet Group Holding NV (TLGHY) Income Statement Analysis – Financial Results
- Aurisco Pharmaceutical Co.,Ltd. (605116.SS) Income Statement Analysis – Financial Results
- Sulzer Ltd (SUN.SW) Income Statement Analysis – Financial Results
- United American Corp, Inc. (UAMA) Income Statement Analysis – Financial Results
- Casa de Bolsa Finamex S.A.B. de C.V. (FINAMEXO.MX) Income Statement Analysis – Financial Results
Horizon Technology Finance Corporation (HRZN)
About Horizon Technology Finance Corporation
Horizon Technology Finance Corporation is a business development company specializing in lending and and investing in development-stage investments. It focuses on making secured debt and venture lending investments to venture capital backed companies in the technology, life science, healthcare information and services, and cleantech industries. It seeks to invest in companies in the United States.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | -9.87M | 26.64M | 33.27M | 10.33M | 21.30M | 14.90M | 12.40M | -1.76M | 14.97M | 20.85M | 7.23M | 7.32M | 14.78M | 15.33M | 16.36M |
Cost of Revenue | 0.00 | 19.98M | 15.96M | 12.66M | 11.58M | -11.61M | 6.12M | 7.72M | 7.90M | 0.00 | 0.00 | -15.14M | 4.19M | 0.00 | 2.20M |
Gross Profit | -9.87M | 6.66M | 17.31M | -2.33M | 9.72M | 26.51M | 6.28M | -9.48M | 7.06M | 20.85M | 7.23M | 22.46M | 10.59M | 15.33M | 14.15M |
Gross Profit Ratio | 100.00% | 25.01% | 52.03% | -22.54% | 45.63% | 177.93% | 50.66% | 539.00% | 47.20% | 100.00% | 100.00% | 306.73% | 71.64% | 100.00% | 86.54% |
Research & Development | 0.00 | 0.30 | 0.49 | 0.20 | 0.50 | 0.41 | 2.10 | -0.20 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 5.67M | 4.78M | 4.69M | 3.75M | 3.41M | 3.04M | 2.87M | 3.24M | 3.46M | 5.26M | 3.48M | 3.10M | 3.45M | 321.00K | 321.51K |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 5.67M | 4.78M | 4.69M | 3.75M | 3.41M | 3.04M | 2.87M | 3.24M | 3.46M | 5.26M | 3.48M | 3.10M | 3.45M | 321.00K | 321.51K |
Other Expenses | 0.00 | -9.38M | 395.00K | -2.64M | -1.85M | -6.36M | -5.17M | -5.88M | -3.95M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 274.38K |
Operating Expenses | 21.57M | 4.78M | 5.08M | 3.75M | 1.56M | 1.86M | 2.79M | 3.24M | 3.11M | 5.26M | 3.48M | 3.10M | 3.45M | 321.00K | 595.89K |
Cost & Expenses | 21.57M | 4.78M | 5.08M | 3.75M | 1.56M | 1.86M | 2.79M | 3.24M | 3.11M | 5.26M | 3.48M | 3.10M | 10.65M | 321.00K | 2.80M |
Interest Income | 110.13M | 77.37M | 54.41M | 42.19M | 37.09M | 28.79M | 23.76M | 31.40M | 28.65M | 28.64M | 31.90M | 25.29M | 22.97M | 14.99M | 4.24M |
Interest Expense | 28.97M | 19.20M | 12.03M | 9.67M | 8.33M | 6.36M | 5.17M | 5.88M | 5.76M | 8.71M | 8.12M | 4.28M | 2.68M | 4.25M | 4.24M |
Depreciation & Amortization | 0.00 | 29.35M | 16.56M | 15.30M | 11.12M | 18.73M | -5.03M | 30.21M | 5.76M | 8.71M | 8.12M | 4.28M | -2.40M | 0.00 | 0.00 |
EBITDA | 11.94M | 0.00 | 0.00 | 0.00 | 0.00 | 19.41M | 9.62M | 22.89M | 0.00 | -3.99M | -9.76M | 16.51M | 14.64M | 14.73M | 13.56M |
EBITDA Ratio | -120.93% | 154.15% | 84.72% | 63.74% | 92.66% | 128.05% | 140.36% | -1,301.31% | 131.99% | 93.95% | 299.28% | 225.52% | 94.82% | 97.91% | 82.89% |
Operating Income | -1.34M | 41.07M | 28.18M | 6.59M | 19.74M | 24.66M | 12.32M | 17.01M | 14.00M | 10.88M | 13.51M | 12.23M | 16.42M | 15.01M | 13.56M |
Operating Income Ratio | 13.56% | 154.15% | 84.72% | 63.74% | 92.66% | 165.48% | 99.34% | -967.14% | 93.52% | 52.18% | 186.90% | 167.01% | 111.05% | 97.91% | 82.89% |
Total Other Income/Expenses | -14.36M | -23.09M | -7.54M | -8.34M | -6.07M | -6.04M | -7.87M | -22.01M | -7.90M | -3.99M | -17.89M | -12.29M | -2.07M | 0.00 | -4.24M |
Income Before Tax | -15.70M | 21.87M | 28.18M | 6.59M | 19.74M | 13.04M | 9.62M | -5.00M | 11.86M | 15.59M | 3.75M | 4.22M | 11.34M | 0.00 | 9.31M |
Income Before Tax Ratio | 159.00% | 82.07% | 84.72% | 63.74% | 92.66% | 87.54% | 77.52% | 284.25% | 79.22% | 74.79% | 51.85% | 57.67% | 76.69% | 0.00% | 56.94% |
Income Tax Expense | 1.49M | 715.00K | 401.00K | 222.00K | 239.00K | 34.00K | 25.00K | -87.00K | 0.00 | 160.00K | 240.00K | 231.00K | 340.00K | 0.00 | -9.31M |
Net Income | -17.19M | 21.15M | 27.78M | 6.36M | 19.50M | 13.01M | 9.59M | -4.91M | 11.86M | 15.43M | 3.51M | 3.99M | 11.00M | 0.00 | 9.31M |
Net Income Ratio | 174.10% | 79.39% | 83.51% | 61.60% | 91.54% | 87.32% | 77.32% | 279.31% | 79.22% | 74.02% | 48.53% | 54.51% | 74.39% | 0.00% | 56.94% |
EPS | -0.56 | 0.86 | 1.39 | 0.36 | 1.45 | 1.13 | 0.83 | -0.43 | 1.06 | 1.60 | 0.37 | 0.47 | 1.44 | 0.00 | 1.23 |
EPS Diluted | -0.56 | 0.86 | 1.39 | 0.36 | 1.45 | 1.13 | 0.83 | -0.43 | 1.06 | 1.60 | 0.37 | 0.47 | 1.44 | 0.00 | 1.23 |
Weighted Avg Shares Out | 30.96M | 24.73M | 20.03M | 17.53M | 13.48M | 11.53M | 11.52M | 11.54M | 11.18M | 9.62M | 9.58M | 8.48M | 7.61M | 0.00 | 7.56M |
Weighted Avg Shares Out (Dil) | 30.96M | 24.73M | 20.03M | 17.53M | 13.48M | 11.53M | 11.52M | 11.54M | 11.18M | 9.62M | 9.58M | 8.48M | 7.61M | 0.00 | 7.56M |
Horizon Technology Finance: Moderately Attractive 11.1% Dividend Yield (Downgrade)
Horizon Technology Finance: Venture Debt Faces A Golden Moment
Horizon Technology Isn't A Sell But TriplePoint Venture Carries Some Risk
4 Reasons to Invest in Horizon Technology (HRZN) Stock Now
Is Horizon Technology Finance (HRZN) Stock Outpacing Its Finance Peers This Year?
3 High-Yield Dividend Stocks That Pay You Every Month
BDC Weekly Review: What Will Happen To BDCs When Rates Move Lower?
Seeking Income? 3 Top-Ranked High-Yield Stocks to Buy
Horizon Technology Finance Provides $15 Million Venture Loan Facility to Tallac Therapeutics
Horizon Technology Finance (HRZN) Q2 Earnings and Revenues Surpass Estimates
Source: https://incomestatements.info
Category: Stock Reports